Stress, meditation, and Alzheimer's disease prevention: Where the evidence stands

Journal of Alzheimer's Disease

Volumn 48, Issue 1, 2015, Pages 1-12

  Khalsa, Dharma Singh ^a,b  

^a Alzheimer Research and Prevention Foundation   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Lifestyle; Meditation; Memory loss improvement; Prevention; Psychospiritual well being; Reduction of risk factors; Stress

Indexed keywords

GLUCOSE; INSULIN; TELOMERASE;

AGING; ALZHEIMER DISEASE; ANTERIOR CINGULATE; BODY POSTURE; BRAIN BLOOD FLOW; BREATHING; CAREGIVER; COGNITION; DEPRESSION; EXERCISE; FINGER; FITNESS; HUMAN; LIFESTYLE MODIFICATION; MEDITATION; MENTAL DETERIORATION; MENTAL HEALTH; MILD COGNITIVE IMPAIRMENT; MINDFULNESS; NERVE CELL NECROSIS; NERVE DEGENERATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATOR GENE; RELIGION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP; SOCIALIZATION; STRESS; THERAPY EFFECT; UPREGULATION; WELLBEING; COGNITION DISORDERS; COMPLICATION; LIFESTYLE; MENTAL STRESS; PROCEDURES; PSYCHOLOGY;

ALZHEIMER DISEASE; COGNITION DISORDERS; HUMANS; LIFE STYLE; MEDITATION; STRESS, PSYCHOLOGICAL;

EID: 84941004394     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-142766     Document Type: Review

References (94)

1. Carrillo MC, Thies W, Bain L (2012) The global impact of Alzheimer's disease. In Advances in Biological Psychiatry, Vol. 28, Alzheimer's Disease-Modernizing Concept, Biological Diagnosis and Therapy; Adv Biol Psychiatry, Hampel H, Carillo MC, eds. Karger, Basel, pp. 1-14.
2. Christensen K, Thinggaard M, Oksuzyan A, Steenstrup T, Andersen-Ranberg K, Juene B, McGue M, Vaupel JW, McGue M, Vaupel JW (2013) Physical and cognitive functioning of people older than 90 years: A comparison of 2 Danish cohorts born 10 years apart. Lancet 382, 1507-1513.
3. Matthews FE, Arthur A, Barnes LE, Bond J, Jagger C, Robinson L, Brayne C; Medical Research Council Cognitive Function and Ageing Collaboration (2013) A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: Results of the Cognitive Function and Ageing Study 1 and 11. Lancet 382, 1405-1412.
4. Kivipelto M, Solomon A, Ahtiluoto S, Ngandu T, Lehtisalo J. Antikainen R, Lars Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J, Mangialasche F, Nissinen A, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H (2013) The Finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER) : Study design and progress. Alzheimers Dement 9, 657-665.
5. Imtiaz B, Tolppanen A, Kivipelto M, Soininen H (2014) Future directions in Alzheimer's disease from risk factors to prevention. Biochem Pharmacol 88, 661-670.
6. Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M (2015) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER) : A randomized controlled trial. Lancet 385, 2255-2263.
7. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10, 819-825.
8. Innes KE, Selfe TK, Brown C, Rose KM, Thompson-Heisterman A (2012) The effects of meditation on perceived stress and related indices of psychological status and sympathetic activation in persons with Alzheimer's disease and their caregivers:Apilot study. Evid Based Complement Altern Med 2012, 927509.
9. De Gage S, Moride Y, Ducruet T, Kurth K, Verdoux H, Tournier M, Pariente A, Begaud B (2014) Benzodiazepine use and risk of Alzheimer's disease: Case-control study. BMJ 349, g5205.
10. Lauterbach EC (2012) Psychotropic drug effects on gene transcriptomics relevant to Alzheimer's disease. Alzheimers Dis Assoc Disord 26, 1-7.
11. Newberg AB, Wintering N, Khalsa DS, Roggenkamp H, Waldman RW (2010) Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: A preliminary study. J Alzheimers Disease 20, 517-526.
12. ReisbergB, ShulmanMB,Torossian C, Leng L, ZhuW (2010) Outcome over seven years of healthy adults with and without subjective cognitive impairment. Alzheimers Dement 6, 11-24.
13. Boyle PA, Wilson RS, Aggarwai NT, Tang Y, Bennett DA (2006) Mild cognitive impairment: Risk of Alzheimer's disease and rate of cognitive decline. Neurology 67, 441-445.
14. Sapolsky R (1992) Stress, the Aging Brain and the Mechanisms of Neuron Death, Bradford, Cambridge.
15. Wilson RS, Arnold SE, Schneider JA, Kelly JF, Tang Y, Bennett DA (2006) Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology 27, 143-153.
16. Cannon WB (1914) The emergency function of the adrenal medulla in pain and the major emotions. Am J Physiol 33, 356-372.
17. Selye H (1959) Perspectives in stress research. Perspect Biol Med 2, 403-416.
18. Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009) Effects of stress throughout the lifespan on the brain, behavior and cognition. Natl Rev Neurosci 10, 434-445.
19. Benson H, Beary JF, Carol MP (1974) The relaxation response. Psychiatry 37, 37-46.
20. Stein-Behrins BA, Sapolsky R (1992) Stress, glucocorticoids and aging. Aging Clin Exp Res 4, 197-210.
21. McEwen B, Sapolsky RA (1992) Stress and cognitive function. Endocrine Rev 7, 284-301.
22. Armanini MP, Hutchins C, Stein BA, Sapolsky RM (1990) Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent. Brain Res 532, 7-12.
23. Innes KE, Selfe TK (2014) Meditation as a therapeutic intervention for adults at risk for Alzheimer's disease-potential benefits and underlying mechanisms. Front Psychiatry 5, 40.
24. Bredesen D (2014) Reversal of cognitive decline: A novel therapeutic program. Aging 6, 707-717.
25. McEwen B (1998) Protective and damaging effects of stress mediators. N Engl J Med 338, 171-179.
26. Zhang G, Li J, Purkayastha S, Tang Y, Zhang H, Yin Y, Li B, Liu G, Cai D (2013) Hypothalamic programming of systemic ageing involving IKK-b, NF-kB andGnRH. Nature 497, 211-216.
27. Hellhammer DH (2008) Neurobehavioral medicine and stress-related disorders in stress. In The Brain-Body Connection. Key Issues in Mental Health, Hellhammer DH, Hellhammer J, eds. Karger, Basel, vol 174, pp. 1-10.
28. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NPV, MeaneyMJ (1994) Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14, 2893-2903.
29. Lupien S, de Leon M, de Santi S, Convit A, Tarshish C, Nair NPV, Thakur M, McEwen BS, Hauger RL, Meaney MJ (1998) Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1, 69-73, 329.
30. Wilson RS, Begeny CT, Boyle PA, Schneider JA, Bennett DA (2011) Vulnerability to stress, anxiety, and development of dementia in old age. Am J Geriatr Psychiatry 19, 327-334.
31. Peavy GM, Lange KL, Salmon DP, Patterson TL, Goldman S, Gamst AC, Mills PJ, Khandrika S, Galasko D (2007) The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biol Psychiatry 62, 472-478.
32. Bornstein AR, Copenhaver CI, Mortimer JA (2006) Earlylife risk factors for Alzheimer disease. Alzheimer Dis Assoc Disord 20, 63-72.
33. Heim C, Newport DJ, Miller AH, Nemeroff CB (2000) Long term neuroendocrine effect of childhood maltreatment. JAMA 284, 2321.
34. Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K, Alderson AL (1999) Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 56, 527-533.
35. Wang HX, Wahlberg M, Karp A, Winblad B, Fratiglioni L (2012) Psychological stress at work is associated with increased dementia risk in late life. Alzheimers Dementia 8, 114-120.
36. MacLullich AM, Ferguson KJ, Wardlaw JM, Starr JM, Deary IJ, Seckl JR (2006) Smaller left anterior cingulate cortex volumes are associated with impaired hypothalamicpituitary-adrenal axis regulation in healthy elderly men. J Clin Endocrinol Metab 91, 1591-1594.
37. Epel ES, Lin J, Dhabhar FS, Wolkowitz OM, Putermann E, Karan L, BlackburnEH (2010) Dynamics of telomerase activity in response to acute psychological stress. Brain Behav Immun 24, 531-539.
38. Lukens JN, Van Deerlin V, Clark CM, Xie SX, Johnson FB (2009) Comparisons of telomere length in peripheral blood and cerebellum in Alzheimer's disease. Alzheimers Dement 5, 463-469.
39. Tyrka AR, Price LH, Kao HT, Porton B, Marsella SA, Carpenter LL (2010) Childhood maltreatment and telomere shortening: Preliminary support for an effect of early stress on cellular aging. Biol Psychiatry 67, 531-534.
40. Price LH, Kao HT, Burgers DE, Carpenter LL, Tyrka AR (2013) Telomeres and early-life stress: An overview. Biol Psychiatry 73, 15-23.
41. Hess WR (1925) Ueber die Wechselbeziehungen Zwischen Psychischen und Vegetativen Funktionen. Schweiz Arch Neurol Psychiatr 16, 36-55.
42. Hellhammer DH (2008) Neurobehavioral medicine and stress-related disorders. In Stress: The Brain-Body Connection. Key Issues in Mental Health, Hellhammer DH, Hellhammer J, eds. Karger, Basel, vol 174, pp. 21-38.
43. Benson H, Beary JF, Carol MP (1974) The relaxation response. Psychiatry 37, 37-46.
44. Benson H (1975) The Relaxation Response, Morrow, New York.
45. Dusek JA, Hibberd PL, Buczynski B, Chang BH, Dusek KC, Johnston JM, Wohlhueter AL, Benson H, Zusman RM (2008) Stress management vs lifestyle modifications on systolic hypertension and medication elimination: A randomized trial. J Alter Complement Med 14, 129-138.
46. Dusek JA, Out HH, Wohlhueter AL, Bhasin M, Zerbinin LF, Joseph MG (2008) Genomic counter-stress changes induced by the relaxation response. PLoS One 3, e2576.
47. Bhasin MK, Dusek JA, Chang BH, Joseph MG, Denninger JW, Fricchione GL, Benson H, Liebermann TA (2013) Relaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion, and inflammatory pathways. PLoS One 8, e62817.
48. Lazar SW, Bush G, Gollub RL, Fricchione GL (2000) Functional brain mapping of the relaxation response and meditation. Neuroreport 11, 1581-1585.
49. Lazar SW, Kerr CE, Wasserman RH, Gray JR, Greve DN, Treadway MT (2005) Meditation experience is associated with increased cortical thickness. Neuroreport 16, 1893-1897.
50. Mandle CL, Jacobs SC, Arcari PM, Domar AD (1996) The efficiency of relaxation response interventions with adult patients: A review of the literature. J Cardiovasc Nurs 10, 4-26.
51. Jacobs GD (2001) Clinical applications of the relaxation response and mind-body interventions. J Altern Complement Med 7 (Suppl 1) , S93-S164.
52. Samuelson M, Foret M, Baim M, Lerner J, Fricchione G, Benson H, Dusek J, Yeung A (2010) Exploring the effectiveness of a comprehensive mind-body intervention for medical symptom relief. J Altern Complement Med 16, 187-192.
53. Biessels GJ, Kappelle LJ (2005) Diabetic Encephalopathy Study Group. Increased risk of Alzheimer's disease in type II diabetes: Insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33, 1041-1044.
54. Dusek JA, Chang BH, Zaki J, Lazar S, Deikin A, Stefano GB,Wohlhueter AL, Hibberd PL, Benson H (2006) Association between oxygen consumption and nitric oxide production during the relaxation response. Med Sci Monit 12, CR1-CR10.
55. Puustinen PJ, Koponen H, Kautianen H, Mantyselka P, VanhalaM (2011) Psychological distress predicts the development of metabolic syndrome: A prospective population based study. Psychom Med 73, 158-165.
56. De la Monte SM, TongM (2014) Brain metabolic dysfunction at the core of Alzheimer's disease. Biochem Pharmacol 88, 548-559.
57. MacClean CRK, Walton K, Wenneberg S, Levitsky DK, Mandarino J,Waziri R, Hillis S, Schnieder,R (1997) Effects of transcendental meditation program on adaptive mechanisms: Changes in Hormone levels and responses to stress after 4 months of practice. Psychoneuroendocrinology 22, 277-295.
58. Alexander C, Langer EL, Newman R, Chandler H, Davies J (1989) Transcendental meditation, mindfulness, and longevity: An experimental study with the elderly. J Personality Social Psychol 57, 950-964.
59. Jevining R (1978) The transcendental meditation technique, adrenal cortical activity and implications for stress. Experientia 34, 618-619.
60. Orme-Johnson D, BarnesVA, SchneiderRH (2011) Effects of the transcendental meditation program on cardiovascular risk factors and clinical events. In Heart and Mind: The Practice of Cardiac Psychology 2nd ed, Allan R, Fisher J, eds, American Psychological Association, Washington, DC.
61. Travis F, Haaga DAF, Hagelin J, Tanner M, Nidich S, Gaylord-King C, Grosswald S, Rainforth M, Schneider R (2009) Effects of transcendental meditation practice on brain functioning and stress reactivity in college students. Int J Psychophysiol 71, 170-176.
62. Kabat-Zinn J (1990) Full catastrophe living: Using the wisdom of your body and mind to face stress, pain and illness, Delacorte, New York.
63. Hotzel B, Carmody J, Vangel M, Congleton C, Yerramsetti SM, Gard T, Lazar S (2011) Mindfulness practice leads to increases in regional brain matter density. Psychiatry Res 191, 36-43.
64. Carlson LE, Garland SN (2005) Impact of mindfulnessbased stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med 12, 278-285.
65. Wells RE, Kerr CE, Wolkin J, Dossett M, Davis RB, Walsh J, Wall R, Kong J, Kaptchuk T, Press D, Phillips RS, Yeh G (2013) Meditation for Adults with Mild Cognitive Impairment: A Pilot Randomized Trial. J Am Geriatr Soc 61, 642-645.
66. Jacobs TL, Epel ES, Lin J, Blackburn EH, Wolkowitz OM, Bridwell DA, Zanesco AP, Aichele SR, Sahdra BK, MacLean KA, King BG, Shaver PR, Rosenberg EL, Ferrer E, Wallace BA, Saron CD (2011) Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology 36, 664-681.
67. MacClean KL, Ferrer E, Aichele SR, Bridwell DA, Zanexco AP, Jacobs TL (2010) Intensive meditation training improves perceptual discrimination and sustained attention. Psychol Sci 21, 829-839.
68. Paller KA, Creery JD, Florczak SM, Weintraub S, Mesulam MM, Reber PJ, Kiragu J, Rooks J, Safron A, Morhardt D, O'Hara M, Gigler KL, Molony JM, MaslarM (2014) Benefits of mindfulness training for patients with progressive cognitive decline and their caregivers. Am J Alzheimers Dis Other Demen 30, 257-267.
69. Lavretsky H, Epel ED, Siddarth P, Nazarian N, St Cyr N, Khalsa DS, Lin J, Blackburn E, Irwin MR (2012) A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: Effects on mental health, cognition, and telomerase activity. Int J Geriatr Psychiatry 28, 57-65.
70. KaszniakAW (2011) Meditation, mindfulness, cognition, and emotion: Implications for community-based older adults programs. In Enhancing Cognitive Fitness In Adults: A Guide to The Use And Development of Community-Based Programs, Hartman-Stein PE, La Rue A, eds. Springer Science & Business Media, LLC, New York, pp. 85-104.
71. Newberg AB, Wintering N, Khalsa DS, Roggenkamp H, Waldman RW (2010) Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: A preliminary study. J Alzheimers Disease 20, 517-526.
72. Newberg AB, Wintering N, Waldman MR, Amen D, Khalsa DS, Alavi A (2010) Cerebral blood flow differences between long-term meditators and non-meditators. Conscious Cogn 19, 899-905.
73. Khalsa DS (2001) Alzheimer's disease. In Integrative Medicine, Rakel D ed, Elsevier Saunders, Philadelphia.
74. Moss AS, Wintering N, Roggenkamp H, Khalsa DS, Waldman M, Monti D, Newberg AB (2012) Effects of an 8-week meditation program on mood and anxiety in patients with memory loss. J Altern Compl Med 18, 48-53.
75. Newberg AB, Iversen J (2003) The neural basis of the complex mental task of meditation: Neurotransmitter and neurochemical considerations. Med Hypotheses 61, 282-291.
76. Streeter CC, Jensen JE, Perlmutter RM, Cabral HJ, Tian H, TerhuneDB (2007) Yoga asana sessions increase brainGABA levels: A pilot study. J Altern Compl Med 13, 419-426.
77. Nash JD, Newberg A (2013) Towards a unifying taxonomy and definition for meditation. Front Psychol 4, 806.
78. Scheff SW, Neftner JH, Nelson PT (2014) Is synaptic loss a unique hallmark of Alzheimer's disease? Biochem Pharmacol 88, 517-528.
79. Scheff SW, Price DA (2003) Synaptic pathology in Alzheimer's disease: A review of ultra structured studies. Neurobiol Aging 24, 1029-1046.
80. Khalsa DS,AmenD, Hanks C, MoneyN,NewbergAN (2009) Cerebral blood flowchanges during chanting meditation. Nucl Med Commun 30, 1-6.
81. Kljajevic V, Grothe MJ, Ewers M, Teipel S (2014) Alzheimer's disease neuroimaging initiative. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease. Neurobiol Aging 35, 1973-1981.
82. Leech R, Sharp DJ (2013) The role of the posterior cingulate cortex in cognition and disease. Brain 137, 12-32.
83. Harrison TM, Weintraub S, Mesulama MM, Rogalski E (2012) Superior memory and higher cortical volumes in unusually successful cognitive aging. J Int Neuropsychol Soc 18, 1081-1085.
84. Luders E, Cherbuin N, Kurth F (2015) Forever Young (er) : Potential age-defying effects of long-term meditation on gray matter atrophy. Front Psychol 5, 1551.
85. Black DS, Cole SW, Irwin MR, Breen E, St. Cyr NM, Nazarian N, Khalsa DS, Lavretsky H (2013) Yogic meditation reverses NF-kB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial. Psychoneuroendocrinology 38, 348-355.
86. Pomykala KL, Silverman DHS, Geist CL, Voege P, Siddarth P, Nazarian N, Cyr St, Khalsa NM, Lavretsky DS, H (2012) A pilot study of the effects of meditation on regional brain metabolism in distressed dementia caregivers. Aging Health 8, 509-516.
87. Devore EE, Grodstein F, Duffy JF, Stampfer MJ, Czeisler CA, Schernhammer ES (2014) Sleep duration in midlife and later life in relation to cognition. J Am Geriatr Soc 62, 1073-1081.
88. Ryff CD, Singer BH, Dienberg LoveG (2004) Positive health: Connecting well-being with biology. Phil Trans R Soc Lond B 359, 1383-1394.
89. Holt-Lunstad J, Smith TB, Layton JB (2010) Social relationships and mortality risk: A meta-analytic review. PLoS Med 7, e1000316.
90. Boyle PA, Buchman AS,Wilson RS, Barnes LL, Bennett DA (2010) Effect of a purpose in life on incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons. Arch Gen Psychiatry 67, 304-310.
91. Chen ST, Siddarrth P, Saito NY, Rueda F, Haight T, Ercoli LM, Miller KJ, Lavretsky H, Barrio JR, Bookheimer SY, Small GW, Merrill DA (2014) Psychological well-being and regional brain amyloid and tau in mild cognitive impairment. Am J Geriatr Psychiatry 22, 362-369.
92. Kaufman Y, Anaki D, Binns M, Freedman M (2007) Spirituality, religious practice may slow progression of Alzheimer's disease. Neurology 68, 1509-1514.
93. Newberg AB (2014) The neuroscientific study of spiritual practices. Jefferson Myrna Brind Center of IntegrativeFaculty Papers, http://jdc. jefferson. edu/jmbcimfp/14, Paper 14.
94. Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler M, Fratiglioni L, Hooshmand B, Khachaturian AS, Schneider LS, Skoog I, Kivipelto M (2014) Advances in the prevention of Alzheimer's disease and dementia. J Intern Med 275, 229-250.